Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists

Details Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists

C - Chemistry, Metallurgy

07

D

C07D 205/04 (2006.01) A61K 31/397 (2006.01) A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/4468 (2006.01) A61K 31/454 (2006.01) A61P 3/10 (2006.01) C07D 207/14 (2006.01) C07D 207/48 (2006.01) C07D 211/58 (2006.01) C07D 211/96 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2416667

This invention provides compounds of Formula (I), wherein R1, R2, R3, W, X, and Z are as defined hereinbefore or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia.

L'invention concerne des composés de formule (I) dans laquelle R1, R2, R3, W, X et Z sont tels que définis dans la description ou sont un sel pharmaceutiquement acceptable de ces éléments. Les composés sont utiles dans le traitement de troubles du métabolisme liés à la résistance à l'insuline ou à l'hyperglycémie.

Affiliated with

Also associated with

Rating

Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1402813